What ethical considerations surround the use of preimplantation genetic diagnosis (PGD) in IVF, and how is this process regulated to ensure responsible and appropriate application?
Gaurav ChauhanContributor
What ethical considerations surround the use of preimplantation genetic diagnosis (PGD) in IVF, and how is this process regulated?
Share
Preimplantation Genetic Diagnosis (PGD) is a procedure used during In Vitro Fertilization (IVF) to screen embryos for genetic abnormalities before implantation. Ethical considerations surrounding PGD mainly revolve around issues such as the selection of desired traits in offspring, the potential for creating designer babies, the destruction of embryos deemed unfit, and concerns about the impact on the concept of natural reproduction.
To address these ethical concerns, PGD procedures are regulated by various guidelines and laws to ensure responsible and appropriate application. Different countries have different regulations in place to oversee PGD. Some common regulations include:
1. Informed Consent: Patients undergoing IVF with PGD must give informed consent, understanding the risks, benefits, and limitations of the procedure.
2. Genetic Counseling: It is often required that individuals considering PGD receive genetic counseling to understand the implications of the genetic testing and the potential outcomes.
3. Oversight by Ethics Committees: Many fertility clinics have ethics committees that review PGD cases to ensure that the procedure is being used ethically and responsibly.
4. Legal Restrictions: Some countries have specific laws governing the use of PGD, such as prohibiting selection based on non-medical traits or limiting the number of embryos that can be tested.
5. Guidelines for Embryo Disposition: Regulations often address the fate of embryos that are deemed unsuitable for implantation, such as donation for research, donation to other couples, or disposal.
6. Monitoring and Reporting: To ensure compliance with
Preimplantation Genetic Diagnosis (PGD) is a procedure used in conjunction with in vitro fertilization (IVF) to test embryos for genetic conditions before they are implanted in the womb. This technology raises several ethical considerations and is subject to regulations intended to ensure its responsible use.
### Ethical Considerations
1. Genetic Selection: PGD allows for the selection of embryos without genetic diseases, but it also raises concerns about the potential for “designer babies.” Critics argue that selecting embryos for non-disease-related traits (e.g., physical appearance, intelligence) could lead to ethical issues related to eugenics and an increased social divide based on genetic “enhancements.”
2. Discrimination: There is a concern that the use of PGD could promote negative attitudes towards individuals with disabilities, implying that their lives are less valuable or that disability should be prevented at all costs.
3. Access and Equity: The high cost of IVF combined with PGD may make these technologies available only to the more affluent segments of society, potentially leading to inequality in access to these advanced reproductive technologies.
4. Psychological Impact: For prospective parents, the decision-making process regarding the use of PGD can be complex and stressful. Ethical considerations also include the psychological impacts on parents who must decide what constitutes a “serious” genetic condition and whether or not to implant an embryo based on genetic screening results.
5. Regulatory Oversight: The need for a balance between allowing